Wet AMD Recurrence Rate in Patients Stable on Three Month Ranibizumab Dosing
Clinical trial NCT01453920 · COMPLETED
Trial details
- NCT number
- NCT01453920
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2012-07-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.